WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on his testimony today before the House Energy and Commerce Subcommittee on Health regarding the drug safety provisions of the discussion draft of the Food and Drug Administration Globalization Act:
